Initial Hot-Fire Testing Successfully Demonstrated the Next-Generation Drop-In Rocket Propellant in Venus’ Rotating Detonation Rocket Engine

SALT LAKE CITY and HOUSTON, Sept. 1, 2026 — Today, CycloKinetics, Inc. announced that it has selected Venus Aerospace and its rotating detonation rocket engine (RDRE) technology to test CycloRP fuel, a drop-in replacement for RP-1/RP-2. CycloKinetics, which produces drop-in propellants designed to work in existing engines without modification, has designed CycloRP, built for higher energy density and cleaner combustion, as a replacement for RP-1 and RP-2. The testing program is sponsored by the United States Air Force Research Laboratory and backed by the Department of War’s Office of the Under Secretary of War for Research and Engineering.

Testing will happen in two rounds. The first, completed in July 2026, evaluated CycloRP’s combustion performance in the RDRE and confirmed the fuel detonates successfully. The second will build on those results to assess CycloRP’s performance as a coolant, circulating the fuel through the engine to help manage temperature, measured against the known cooling performance of RP-1/RP-2. Results from both rounds will feed into a fuller technical readout expected in early 2027.

“We built CycloRP to be a true drop-in replacement, no engine redesign, no compromise on performance, and testing it in a live rotating detonation rocket engine, backed by the U.S. Air Force, is exactly the kind of real-world validation this technology needs,” said Mukund Karanjikar, CEO and founder of CycloKinetics. “Our work with Venus Aerospace serves as a strong example of how domestically produced propellants can support the next generation of hardware, manufactured right here in the U.S.”

“Our flight-proven rotating detonation rocket engine is changing what’s possible in propulsion. Efficient fuel is a critical piece of getting there,” said Sassie Duggleby, Co-Founder and CEO of Venus Aerospace. “This testing gives the Air Force and CycloKinetics the chance to see how a domestically produced, drop-in propellant performs in real hot-fire testing, side by side with the fuels we know today. Testing like this is how we get to a different economics of space.”

This testing builds upon previous testing CycloKinetics and Venus conducted in June 2025 at Venus’ Houston facility. This new program builds on that work and reflects continued momentum for both companies.

Both companies plan to share updates once final testing has concluded.

About CycloKinetics
CycloKinetics, headquartered in Salt Lake City, Utah, is an advanced technology company developing high-performance, fully drop-in propellants and fuels for aerospace and defense applications. Its proprietary propellants are designed to outperform conventional propellants and fuels while integrating seamlessly into existing systems, enabling improved range, endurance, payload capacity, and overall mission performance. Its propellants are drop-in replacements for the current propellants and fuels which power turbine-powered platforms including Unmanned Aircraft Systems (UAS) for Counter-Unmanned Aircraft Systems (C-UAS) and Collaborative Combat Aircraft (CCA) applications, long-range and attritable missiles, next-generation propulsion, space launch systems, and commercial jets.

CycloKinetics produces its propellants domestically, supporting secure and rapidly scalable supply for defense and aerospace customers. Its industrial manufacturing facility in Salt Lake City became operational in 2025, with deliveries to customers already underway. The company’s feedstock-flexible production process enables manufacturing to be optimized for locally available resources, strengthening supply chain resilience and supporting distributed and in-theater production capabilities. For more information, visit www.cyclokinetics.com 

About Venus Aerospace
Venus Aerospace is building next-generation propulsion systems for defense, space, and future high-speed flight. Founded in 2020 and headquartered in Houston, Texas, Venus is developing flight-proven Rotating Detonation Rocket Engine (RDRE) technology designed to deliver greater efficiency, range, and scalability for defense and space missions. Venus’ propulsion systems are designed for domestic manufacturing and mission flexibility across national security and aerospace applications. Venus is backed by Mercury Fund, Lockheed Martin Ventures, Prime Movers Lab, Airbus Ventures, Trousdale Ventures and others. To learn more, visit www.venusaero.com.

Media Contacts:
Kate Gundry
[email protected]
617-797-5147

Sarah Boland Heine
Head of Communications
[email protected] 
502-471-6186

SOURCE Venus Aerospace

Financing led by The Venture City, Capital Factory, Scalpel Ventures and Evoce Capital; funds will be utilized to run multiple clinical studies in oncology to advance a novel and revolutionary red blood cell based liquid biopsy platform invented at the University of Pennsylvania.

PHILADELPHIA, Sept. 1, 2026 — Senticell, Inc. (“Senticell” or the “Company”), a biotechnology company pioneering a new class of liquid biopsy built on red blood cell (RBC)-bound nucleic acids, today announced the closing of an oversubscribed seed financing round approaching $7 million. The round drew participation from The Venture City, Capital Factory, Scalpel Ventures, Evoce Capital, as well as a group of high-net-worth individuals.

“This financing reflects strong investor conviction in the underlying science and in our team’s ability to translate that science into a scalable diagnostic platform,” said Neha Shah, Co-founder and Chief Executive Officer of Senticell. “Being oversubscribed and welcoming a group of investors who understand the clinical need firsthand, gives us both the capital and the opportunity to rapidly advance what will be a major breakthrough in cancer diagnosis and ultimately treatment decision-making.”

Senticell’s liquid biopsy platform is exclusively licensed to the company from the University of Pennsylvania and is built on more than a decade of published, peer-reviewed research demonstrating red blood cells actively bind and retain disease-associated DNA and RNA. These unique insights were first identified by Dr. Nilam Mangalmurti, who is the scientific co-founder of Senticell and acts as the company’s Chief Scientific Advisor.

Since red blood cells are the body’s most abundant cell type (an estimated 30 trillion in circulation), remain in circulation for roughly 120 days, and come into contact with every tissue in the body, they represent a largely untapped molecular diagnostic reservoir that can significantly lower limits of detection of liquid biopsy. Senticell is rapidly advancing a proprietary RBC liquid biopsy platform to identify clinically actionable disease signals in oncology that today’s plasma-based tests miss and enable more consistent application in early-stage disease and low-shedding tumor states.

“Decades of research suggested that red blood cells were doing far more than carrying oxygen. Our discovery that red blood cells bind nucleic acids revealed that they could provide a distinct window into disease—one that may capture information not readily accessible through conventional liquid biopsies. Importantly, we recognized that this biology could be harnessed for diagnostics. That insight led to the development of a new technology to isolate and rapidly analyze RBC-associated nucleic acids, including oncogenic driver mutations. We are now building on this discovery to develop a reliable diagnostic platform with the potential to transform cancer detection and improve patient lives,” said Dr. Mangalmurti.

Central to Senticell’s data package are two prospective clinical studies currently underway at Penn Medicine, together enrolling approximately 300 patients and comparing Senticell’s red-cell signal against plasma-based tests and determining tissue concordance. The company is actively enrolling 200 lung and pancreatic cancer patients at UPenn, evaluating pre-surgical driver detection and recurrence monitoring, with completion in Q1 2027. In addition, Senticell is providing RBC-based in-vitro analytical support for a clinical study (head & neck and cervical cancer cohorts, ~100 patients across UPenn and UPenn-Botswana) evaluating MRD and post-treatment monitoring, with results expected in Q4 2026. Finally, foundational work under Senticell’s Sponsored Research Agreement with Penn Medicine is establishing rapid, culture-independent pathogen detection for sepsis and pneumonia on the RBC platform; the Company expects to formalize this into a dedicated clinical study following the completion of its oncology proof-of-concept work.

With its transformative technology based on decades of research, Senticell has attracted a world-class scientific advisory board including:

• Steven Albelda, MD (Penn Medicine, Emeritus), a tumor immunologist and co-founder of Capstan Therapeutics (acquired by AbbVie)
• Chris Hunter, PhD (Penn Vet), a cytokine biologist and founder of Surface Oncology (acquired by Coherus)
• David Roth, MD, PhD (Penn Medicine, Emeritus), founder of the Center for Personalized Diagnostics at UPenn.

“I have closely followed Dr. Mangalmurti’s research at Penn. Senticell will translate these basic science findings into clinically applicable RBC-platforms that will be more sensitive, more rapid, and less expensive than currently available testing approaches in diseases like cancer and infections,” said Dr. Steven Albelda, Scientific Advisor to Senticell.

Looking ahead, Senticell views this seed round as the foundation for a much broader platform. “Red blood cells have been hiding in plain sight as a diagnostic tool for decades, and we are just beginning to unlock what they can tell us,” said Shah. “Our vision is to build the definitive RBC-based diagnostics platform, one that starts in oncology but ultimately extends across disease areas where earlier, more sensitive detection can change how patients are treated. This is the first step toward making that a reality.”

About Senticell

Senticell is a biotechnology company developing a new class of liquid biopsy diagnostics based on red blood cell (RBC)-bound nucleic acids. Founded on research pioneered at Penn Medicine, Senticell’s platform is designed to unlock disease signals that plasma-based liquid biopsy often cannot detect, with initial applications in oncology and infectious diseases. Senticell holds an exclusive, worldwide license to its foundational RBC platform from the University of Pennsylvania and is based in Philadelphia, Pennsylvania. For more information, visit www.senticell.bio.

SOURCE Senticell

SAN FRANCISCO, Sept. 1, 2026 – Tripo AI, the world’s leading AI company in generative 3D, has raised approximately 3 billion yuan in its Series B and Series B+ financing rounds as the company announced a major breakthrough in AI 3D generation.

Led by MPCi, the latest funding attracted a diverse set of institutions from various sectors. Major strategic and industry investors included Perfect World, BlueFocus, SPC, Yanqu Games, ThunderSoft, and 37 Interactive Entertainment. The financing rounds were also backed by financial investors such as CDH Venture and Growth Capital, CICC, CMC Capital Partners, Hongtai Aplus, 3H Health, Zhongping Capital, and GreatOrigin Asia. Existing investors Fortune Capital, Primavera Capital, 4399 Network, Muhua Tech Ventures, Vitalbridge Capital, INCE Capital, and T-Capital further increased their investments.

The completion of the financing rounds came as Tripo announced a major breakthrough in 3D-native foundation models with the preview release of Tripo P2.0, its latest 3D-native foundation model that allows quad topology, a first for the industry. As an upgrade from Tripo P1.0, P2.0 enables the generation of high-quality and production-ready 3D objects in mere seconds.

Enterprises across industries have deployed Tripo’s 3D-native foundation models as the company continues to push the boundaries of what AI 3D technology can achieve. The latest financing rounds reinforce the leading status of Tripo AI in generative 3D.

The funding will accelerate the development and advancement of 3D-native foundation models and 3D data infrastructure, expand computing infrastructure for AI training and inference, and fuel product development and commercialization.

About Tripo AI

Tripo AI is a global leader in the development of 3D-native foundation models and world models. Founded in 2023 by leading scientists in AI and computer graphics, the company has developed a comprehensive end-to-end product ecosystem, built around its proprietary 3D-native foundation models and world models. With Tripo Studio and Tripo API, Tripo AI has transformed 3D generation. Powered by a world-class AI 3D research team, the company is advancing AI toward understanding, generating, and interacting with 3D environments.

Tripo AI’s models and products have been widely adopted by individual users and enterprises globally, serving industries including intelligent manufacturing, virtual reality, interactive entertainment, and embodied AI, empowering enterprises to unlock new productivity and scale applications of generative 3D.

Yinyin Wang
[email protected]

SOURCE Tripo AI

Silicon Valley technology company advances enterprise adoption through an integrated AI-powered ecosystem connecting payments, commerce, logistics and travel

PALO ALTO, Calif., Sept. 1, 2026 — PayToMe.co, a Silicon Valley AI and financial technology company, today announced the continued global expansion of its AI-powered commerce platform, connecting FinTech, commerce, logistics and travel through an integrated ecosystem serving consumers and enterprises in the United States and international markets.

Businesses and consumers operate in a world where money, commerce, goods and people move continuously, yet the technology supporting those activities remains fragmented across payments, financial operations, customer engagement, fulfillment, logistics and service. PayToMe.co connects that journey through technology designed to make complex transactions simpler, faster and more intelligent.

The company is accelerating enterprise adoption, strategic relationships and international reach while continuing to advance AI, automation, embedded FinTech and enterprise APIs.

Intelligence Behind the Network

PayToMe.co and its internal software development team have developed technology designed to intelligently orchestrate financial and commerce workflows across one connected environment.

Its platform combines AI, intelligent workflow automation, embedded payments, Text-to-Pay, digital invoicing, KYC/KYB, financial management, data intelligence and enterprise APIs to reduce manual processes across transactions, payments, customer engagement and workflow execution.

The PayToMe.co ecosystem connects with approximately 12,000 financial institutions and 7,000 applications through integrated financial technology networks. Its technology and service ecosystem includes AWS, Stripe, Plaid, Intuit QuickBooks, FedEx, UPS and DHL. PayToMe.co has received support from Startupbootcamp and Hatcher+, also participates in IBM Partner Plus and NVIDIA Inception.

PayToMe.co is designed to connect capabilities businesses already need and make them easier to access, automate and distribute. Through LuggageToShip.com, ShipAndStorage.com and ShipToBox.com, PayToMe.co extends its ecosystem across travel logistics, technology-enabled storage and domestic and international shipping.

One platform. One API. Global reach.

AI Connects Transactions to Their Destinations

Artificial intelligence is rapidly evolving from generating information toward executing real-world business processes. PayToMe.co applies AI as operating intelligence across its platform, helping software understand transactions, payments, destinations, customer requirements and available options while automating activities that traditionally require multiple companies, systems and manual decisions.

“AI provides the intelligence. FinTech moves the money. Commerce drives transactions. Logistics moves the goods. Travel moves the people. PayToMe.co connects the journey,” said Mike Ulker, CEO of PayToMe.co.

Built for a World That Never Stops Moving

Global business is becoming more digital, mobile and complex. Supply-chain volatility, inflationary pressure, cybersecurity risk, geopolitical uncertainty and climate-related disruption are increasing demand for flexible, connected infrastructure. At the same time, businesses face rising expectations for instant payments, automation, digital verification and seamless connections between online transactions and physical commerce.

PayToMe.co operates at this intersection, connecting financial technology, AI, commerce, logistics, storage and travel through an integrated ecosystem supporting services across up to 220 countries and territories.

Designed to work across existing business environments, PayToMe.co helps enterprises connect customer experiences, automate workflows and extend capabilities without independently building every financial, commerce or logistics function.

PayToMe.co combines its proprietary technology, internal software development capabilities and established commercial platforms to connect financial technology with real-world commerce—creating scalable infrastructure that helps businesses and consumers operate across domestic and global markets.

Businesses seeking to integrate payments, intelligent automation, commerce or logistics capabilities—and organizations interested in strategic partnerships—can learn more at www.paytome.co or contact [email protected]

About PayToMe.co

PayToMe.co is a Silicon Valley AI and financial technology company providing an integrated platform connecting payments, financial operations, intelligent automation and global commerce. Its ecosystem includes LuggageToShip.com, ShipToBox.com and ShipAndStorage.com, extending the company’s reach across commerce, logistics, storage and travel while supporting customers across the United States and international markets.

SHOP. SHIP. STORE. TRAVEL. PAY. Powered by PayToMe.co.

Learn more at www.paytome.co

Media and Partner Contact: [email protected]

Media Contact
Mike Ulker
(650) 963 4969
[email protected]

SOURCE PayToMe.co

LAKE FOREST, Calif., Sept. 1, 2026 — Sonorous Neurovascular, a medical device company focused on cerebral venous diseases and neurovascular interventions, today announced that  it has enrolled its first patient at a Toronto hospital in B-SILENT (NCT07070089), an international clinical study evaluating an investigational cerebral venous stent for patients with debilitating pulsatile tinnitus associated with symptomatic cerebral venous sinus stenosis. The clinical evaluation is being led by Dr. Vitor Mendes Pereira, neurosurgeon and Director of Endovascular Research and Innovation at St. Michael’s Hospital in Toronto, Canada.

The B-SILENT study is evaluating the investigational use of BosSTENT™, Sonorous’ braided, self-expanding cerebral venous stent, for the treatment of debilitating pulsatile tinnitus caused by symptomatic cerebral venous sinus stenosis. The study is designed to generate essential safety and performance data to support a future CE Mark submission.

St. Michael’s and The Ottawa Hospital are Canadian sites in B-SILENT, extending the study’s international enrollment beyond France, where four clinical sites are participating. The collaboration across French and Canadian centers reflects growing clinical interest in generating rigorous evidence for the treatment of pulsatile tinnitus associated with cerebral venous sinus stenosis.

At St. Michael’s, B-SILENT is coordinated through the RADIS Lab, with Eileen Liu and Alphonse Potvin providing clinical support for the study.

“The expansion of B-SILENT into Canada is an important step for the study and for patients living with debilitating pulsatile tinnitus,” said Joel Harris, CEO of Sonorous Neurovascular. “We are grateful to Dr. Pereira and the St. Michael’s team, Dr. Fahed and the team at The Ottawa Hospital, and our colleagues across France for their commitment to advancing this research. Their collaboration is essential to building the clinical evidence needed to evaluate this investigational therapy.”

“Pulsatile tinnitus can be extremely debilitating, yet patients often spend years searching for an explanation and an effective treatment. In appropriately selected patients, venous sinus stenosis can be an important underlying cause. B-SILENT gives us the opportunity to rigorously evaluate a technology specifically designed for the cerebral venous system and, ultimately, to build the evidence needed to improve how we treat these patients,” said Dr.  Pereira.

Sonorous Neurovascular continues to progress its clinical programs across both U.S. and international regulatory pathways, building on the company’s FDA Breakthrough Device Designation for BosSTENT™ and 510(k) clearance for BosCATH™. These achievements support Sonorous’ mission of improving the lives of patients affected by pulsatile tinnitus and other venous outflow disorders through minimally invasive, purpose-built therapies.

About Sonorous Neurovascular

Sonorous Neurovascular is a clinical-stage medical device company headquartered in Lake Forest, California, dedicated to developing transformative technologies for the treatment of cerebral venous diseases. The company’s innovative portfolio, including the BosSTENT™ (recently granted FDA Breakthrough Device Designation) and BosCATH™, aims to provide safe, effective, and purpose-built solutions that improve patient outcomes. Sonorous is actively advancing international clinical research, including the B-SILENT study (NCT07070089) evaluating the investigational use of BosSTENT™ for debilitating pulsatile tinnitus at sites in France and Canada to support CE Mark submission. For more information, visit www.sonorousnv.com.

Contact:
James D. Nonato, Vice President
Sonorous Neurovascular
Email: [email protected]
Phone: +1 (888) 830 1445

SOURCE Sonorous Neurovascular

DataAgent autonomously fixes production faults inside an organization’s own infrastructure so incidents close faster and engineering teams stop paying to ship their data to an outside vendor

TEL AVIV, Israel, Sept. 1, 2026 — DataAgent, the developer of a remediation-first Digital Immune System (DIS) for modern applications, today announced that the company has emerged from stealth with the launch of its platform and the closing of a $10 million pre-seed funding round.

DataAgent’s pre-seed funding round was led by MizMaa Ventures and Alicorn Venture Partners. DataAgent intends to use the proceeds from this funding to bring its remediation-first platform to market and accelerate customer adoption in North America.

DataAgent is led by the company’s two Co-Founders Ishay Yaari (CEO) and Nati Shalom (CTO), who worked together at Cloudify, a cloud orchestration company acquired by Dell in 2023. The company currently has a team of 15 and is actively recruiting additional go-to-market staff in the United States and Israel.

DataAgent’s remediation-first platform acts as an AI-native autonomous SRE (site reliability engineer) for Kubernetes and connected infrastructure. The platform operates directly within cloud-native control planes and integrates with existing observability systems as a lightweight overlay rather than a replacement.

The platform deploys agents to capture high-fidelity signals at the source and acts autonomously to remediate issues the moment a fault occurs, which eliminates the need for expensive external data transfers. By forwarding only relevant data for deeper inspection when a fault requires it, the DataAgent platform enables teams to drastically lower their observability bill without downtime or the risk of a full migration.

“In DataAgent, observability is just one feature – the real product is a self-healing infrastructure,” said Ishay Yaari, Co-Founder and CEO of DataAgent. “We pair a production remediation engine that fixes failures after they happen with a pre-production engine that blocks them before code ever ships. And they are not separate products: prevention and remediation are fused into one continuous lifecycle, so the system gets smarter with every failure it stops and every incident it resolves.”

“Applying rapidly evolving AI technology to major pain points with transformational results is the holy grail”, said Catherine Leun, Co-Founder and Partner at MizMaa Ventures. “DataAgent is doing exactly that by moving observability beyond insight and toward action.”

“DataAgent is attacking one of the most expensive and persistent problems in modern software infrastructure: systems that can tell engineers something is broken, but cannot safely fix it,” said Alexander Assim, Managing Partner of Alicorn Venture Partners. “What attracted us to DataAgent is the company’s ability to combine autonomous remediation with a deployment model that keeps customer infrastructure and telemetry under the customer’s control.”

Reversing the Order of Operations

Conventional observability platforms detect a fault and route it to an engineer, who then investigates and applies a fix. This model requires a second, paid copy of a customer’s telemetry – the logs and metrics a system produces about itself – to be shipped to a vendor’s cloud. This process grows more expensive as the system it watches grows. Observability spending now averages 17% of total compute infrastructure spending, according to Grafana Labs’ 2025 Observability Survey.

DataAgent reverses that order. The platform reads live system state, topology and configuration drift where the data already sits, identifies the cause of an incident and applies a verified fix. A deeper root-cause analysis is run offline after the service is restored. By restoring service first, rather than waiting on deep diagnostics, DataAgent dramatically shortens mean-time-to-resolution (MTTR). Telemetry never leaves the customer’s environment because the platform runs directly inside their own cluster and integrates alongside existing observability tools rather than replacing them.

“Traditional observability is hitting a wall of complexity and cost,” according to the research analyst firm Gartner. “Agentic AI breaks down silos and accelerates root cause analysis by moving from explanation to action. This collaborative approach enables self-healing and self-optimizing systems, bridging the gap from data to insight to action.”

Platform Capabilities

Four elements of the platform’s design enable support for autonomous remediation:

• Remediation-first – the platform autonomously resolves incidents in real-time and restores uptime using safe, guardrail-controlled actions the user defines rather than relying on traditional approaches to root-cause analysis that require expensive data ingestion transfers.
• 360-degree architectural context – the platform builds a working model of the customer’s topology, environment, code and configuration rather than acting on isolated logs and traces. A fix applied to a misread system state carries real risk, so precision determines what the platform can safely do on its own.
• Continuous reinforcement learning – during onboarding, the platform runs a discovery phase that shows a customer which classes of failure it can already remediate and sets out a timeline for closing the remaining gaps. The platform adapts to new failure modes over time and acts autonomously on a class of fault only once it has been proven correct on that class, while other cases are routed for human intervention, deployable through the user’s existing change-management process or a single CLI command.
• An open-source agent – the platform’s agent is open source and can be deployed and run standalone at no cost with a paid SaaS tier for fleet management and orchestration. This approach addresses enterprise resistance to running closed software inside production environments.

“The industry has spent 15 years building better ways to watch production and charging more for it every year. Legacy tools have become data-heavy and reactive, while recent attempts to bolt AI copilots onto this broken model have not changed the outcome,” explained Nati Shalom, Co-Founder and CTO of DataAgent. “We have built DataAgent the other way around. Our platform and agents act where the data already sits, restore health first and earn autonomy one fault class at a time. Autonomy is not an add-on feature for observability; it is a fundamental architectural shift that slashes costs as a direct result.”

Financial Impact

The design of the DataAgent platform includes two important financial benefits for customers:

• Adoption without replacement – customers can run the DataAgent platform above their existing monitoring stack, where it resolves routine faults locally and forwards data for deeper inspection only when a fault requires it. Teams see results without the downtime and the risk of a full migration, while drastically lowering their observability bill.
• Analyzing telemetry locally – instead of ingesting and indexing terabytes of redundant logs, DataAgent’s root cause analysis engine focuses deep inspection on the small fraction of code paths that dictate stability. This dramatically scales down expensive log-indexing pipelines, yielding a far lower cost structure than legacy tools.

“In ten years, no one has ever heard an engineering leader say their organization’s observability costs went down and that is no accident,” said Yaari. “When a vendor’s revenue is your data ingest, it cannot cut your bill without cutting its own. DataAgent can run alongside your existing tools, while filtering out the noise and rerouting data only when an incident demands it. There is no need for an expensive second copy of your data and everything pulled live from the source so customers can cut up to 90% of their observability spend.

About DataAgent

DataAgent is building a Digital Immune System for modern applications: a private, enterprise-grade, remediation-first platform designed to replace legacy observability tools. Founded in January 2026 and led by CEO Ishay Yaari and CTO Nati Shalom, the company prioritizes real-time autonomous remediation, including restarting, scaling and rolling back workloads, over conventional root-cause analysis. By processing in-cluster and working from a focused set of core metrics, DataAgent removes the need for large data ingestion pipelines. The company has operating infrastructure in the United States and Israel and closed a $10 million pre-seed round in 2026 led by MizMaa Ventures and Alicorn Venture Partners. For more information, please visit www.data-agent.co.

SOURCE DataAgent

Berkeley-rooted company unveils algorithmic neuroscience platform for political polling, messaging, fundraising and voter persuasion

BERKELEY, Calif., Sept. 1, 2026 — Amygdala Corp., www.amygdala.com, whose technology successfully predicted a key upset in recent Wisconsin primaries, is bringing a disruptive new technology platform to politics: Algorithmic Neuroscience.

Built on technology developed by neuroscience and engineering teams with Berkeley roots, Amygdala is pioneering NeuroPolitics — the application of neuroscience to political strategy.

“We had tremendous success applying neuromarketing to some of America’s leading brands,” said Dr. A.K. Pradeep, Amygdala chairman and co-founder. “Now we are taking those neuroscience insights from brand and market competition and applying them to something even more consequential: helping candidates win elections.”

Amygdala is built on cutting-edge science and engineering. Dr. A. K. Pradeep’s latest foundational work on neural state reduction becoming reportable thought has been accepted for publication in the peer-reviewed Frontiers of Computational Neuroscience, a multidisciplinary journal that focuses on the theoretical modeling of brain function.

The company draws on a team with decades of neuromarketing experience with major global brands to model how voters respond at a non-conscious level. Its technology focuses on two powerful neural systems: the limbic mechanisms underlying threat and emotional response, and the brain mechanisms that create Desire.

Pradeep previously founded NeuroFocus, which was acquired by Nielsen (NiQ) and became a global leader in neuromarketing. Amygdala applies these principles across political messaging, polling, voter-level issue framing and fundraising. The platform is already being deployed in congressional, gubernatorial and state legislative races across the Midwest.

Its synthetic polling moves beyond conventional digital personas. Amygdala creates neuroscience-grounded Dynamic Digital Twins using neurographic profiles of real voters. The approach combines neural-state modeling to deliver polling that is faster, less expensive and designed to capture the forces underlying voter choice.

“NeuroPolitics models what voters actually feel beneath conscious reporting — not simply what they say,” said Devin Pracar, Amygdala co-founder and VP of Product.

Amygdala continues expanding its leadership network. The company recently added Caroline Winnett, executive director of SkyDeck, the startup ecosystem of U.C. Berkeley to its advisory board. She joins the board that includes veteran Democratic strategist Joe Trippi, and political strategist Alex Shashlo.

“We are assembling extraordinary expertise across politics, neuroscience, technology and entrepreneurship,” said Dr. Robert Tatterson, CEO of Amygdala. “The sky is the limit for Amygdala as a company, and the field of NeuroPolitics.”

About Amygdala

Amygdala is a political technology company at the intersection of neuroscience, artificial intelligence and political strategy. Its NeuroPolitics platform uses Algorithmic Neuroscience to understand non-conscious voter response, generate advanced polling insights, optimize political messaging and help campaigns turn voter understanding into electoral advantage.

Contact:
Mike Smith
Chief Political Officer
Amygdala
[email protected]
703-623-3834

SOURCE Amygdala

AMSTERDAM, Sept. 1, 2026 — DataSnipper, the agentic platform for audit and finance, today announced that Standish Management, a leading fund administrator serving private equity, venture capital, and other alternative investment funds, is leveraging DataSnipper’s AI Agents as part of its broader technology strategy to increase efficiency across its fund administration workflow.

As fund structures, reporting requirements, and investor expectations grow in complexity, Standish continues to invest in people, processes, and technology that support scalable, high-quality fund administration. Using DataSnipper’s Agentic platform, Standish has developed AI agents to work together with its highly experienced teams to automate certain tasks across processes such as investor relations, journal entries, workflow tracking, and reporting. For Standish and its clients, DataSnipper’s AI Agents enable its teams to provide enhanced value to clients through greater efficiency, faster turnaround times, greater insights, and enhanced quality.  In addition, it enables Standish’s industry leading experts to spend more time engaging with clients as thought partners.   

Working inside the native files and workflows teams already use, DataSnipper automates document-intensive processes without requiring teams to fundamentally change how they work. The platform keeps traceable links to the source document behind each figure, then matches, extracts, and compares the data, so Standish’s teams perform reviews efficiently, while preserving appropriate controls in a manner consistent with Standish’s proven, time-tested processes.

With DataSnipper’s human in the loop approach, a Standish expert stays in control at every judgment point, and every result links back to its exact source document. For a firm whose name goes on everything it sends to clients, the traceability that DataSnipper provides is what lets its teams verify and stand behind their work.

 “Our goal is not to replace expertise with automation. It’s to give our team better tools,” said Linda Jones, Managing Director and Co-Head of Client Solutions & Technology at Standish Management. “By reducing time spent on manual data gathering and validation, our teams can focus more attention on analysis, oversight, and responsiveness to our clients. We see DataSnipper as a way to enhance the client experience while maintaining the high standards of quality and accountability that define our service model,” added Alexa O’Hare, Managing Director and Co-Head of Client Solutions & Technology at Standish Management.

How Standish Management Is Using DataSnipper

As part of its broader investment in technology and operational excellence, Standish is putting DataSnipper’s AI Agents to support a number of workflow-specific activities within its fund administration operations. These are the high-volume, document-heavy tasks that run through a fund administrator every day, from extracting and validating incoming data to reconciling records and preparing information for review and reporting. Using DataSnipper’s Agent Builder, the firm has turned its procedures into reusable agents its teams can run firmwide. As the agents take on the repetitive work in bulk, Standish’s people get more time for the review, judgment, and client service the firm is known for.

“Standish is exactly the kind of forward-thinking firm we love to work with,” said Vidya Peters, CEO of DataSnipper. ” They saw how much AI could do for the speed and quality of the work they deliver to clients, and they’ve built over 50 agents across their fund administration process   They are among the first fund administrators to adopt agents at this scale, while keeping their people in control of every result. We’re proud to support Standish’s team as they raise the bar for clients.”

As more firms weigh how to bring AI into their work, Standish is at the forefront of embedding AI into its fund administration workflows in a responsible manner: agents working across the process, people accountable for every result. As the first fund administrator to work with DataSnipper to build agents, and a DataSnipper design partner, the firm will keep expanding its use of AI Agents and help put new capabilities to work first.

Learn more about DataSnipper’s agentic platform for audit and finance at datasnipper.com.

About DataSnipper

DataSnipper is the agentic platform transforming audit and finance. Powered by AI Agents, DataSnipper helps professionals reduce manual work, accelerate document analysis, and streamline complex workflows while maintaining full transparency and control. Trusted by Fortune 500 companies, government agencies, global enterprises, and all Big Four accounting firms, DataSnipper is used by professionals across 175 countries. In 2025, the company delivered more than $1.4B in productivity savings to its customers.

About Standish Management

Standish is the leading independent provider of fund administration and related services to the private capital industry. With more than 1,200 professionals across 19 offices in North America, Europe, Africa, and Asia, Standish provides comprehensive solutions for Fund Sponsors, including: fund administration, management company, tax, compliance, as well as corporate and depositary services for its clients in Europe. The firm supports over 500 clients with over $850 billion in assets under administration and serves all major alternative asset classes.

Media Contact
Chloe Shoobridge
(+31) 20 211 76 54
[email protected]

SOURCE DataSnipper

Newlight’s retrofit transforms existing diesel engines into intelligent hybrid energy systems, combining hydrogen with AI-guided real-time combustion control to enable significantly higher energy efficiency and lower emissions.

The voyage represents a major commercial milestone for Newlight and the maritime industry. It marks Newlight’s transition into multi-vessel deployment while demonstrating a new pathway for the future of maritime energy.

Based on the measured performance, the system is projected to save similar vessels $500,000 annually, with a payback period for the technology of under 18 months.

“In a world where energy demand is accelerating, from global trade and shipping to AI and data centers, getting more useful work out of every unit of energy is becoming increasingly important. That is exactly where Newlight fits. We are building a new energy layer for the diesel engines already powering the global economy, making them materially more efficient and cleaner without requiring them to be replaced,” said Haran Cohen Hillel, Co-Founder and CEO of Newlight. “The vessel didn’t need to change how it operated. We simply gave its existing engine a way to do more, and it did so successfully across thousands of miles at sea.”

Commercial Traction

Newlight has signed commercial agreements covering 12 vessels across multiple shipping companies, with broader fleet rollouts planned for next year.

Newlight’s partners throughout this journey include lomarlabs, Undeterred Capital, CiRi Ventures, Fusion VC, BIRD Energy, AURELIA, and RINA.

“Our lomarlabs vision is to support novel ways of increasing energy efficiency and reducing shipborne emissions. When we first connected with Newlight we were drawn by the promise that its technology could cut fuel and emissions at cost levels that appeared commercially viable and sustainable,” said Stylianos Papageorgiou, Managing Director at lomarlabs. “We then admitted Newlight into our Compass Programme and became an investor to put that promise to the test. This voyage has demonstrated that hydrogen can safely be managed and used onboard, to enhance the combustion of HFO and reduce emissions. It therefore provides a new pathway for sustained compliance within the IMO 2050 framework for existing and aging vessels.”

A Retrofit, Not a Replacement

Newlight’s retrofit approach – installed in one to two weeks on traditional diesel engine vessels in the water, without needing to drydock – allows operators to start cutting both fuel costs and emissions immediately, without having to wait for delivery of a newbuilding vessel or a global alternative-fuel infrastructure that doesn’t exist at scale and likely will not be commercially available for years to come. Vessels can also continue operating during installation so there is no downtime.

Unlike ammonia- or methanol-based alternatives, which require vessels to depend entirely on a new fuel, Newlight’s system injects a small proportion of hydrogen into a ship’s existing diesel combustion process. A real-time controller anticipates each combustion cycle milliseconds in advance, continuously optimizing hydrogen injection pressure and volume as engine load, speed, and operating conditions change.

The system also allows vessels to run on diesel alone if hydrogen isn’t available, removing the infrastructure dependency and risk that has traditionally slowed down adoption of other alternative-fuel systems in shipping. The Newlight system has received regulatory approval from RINA, the globally recognized classification and regulation society, which also named the company the winner of its Hydrogen Innovation Award.

An Industry Under Pressure to Change

Global shipping moves more than 80% of world trade by volume and burns an estimated 250–300 million tons of fuel a year, at a cost of over $150 billion annually – typically comprising about half of all costs and the largest single line item in a vessel’s operating budget.

Moreover, EU carbon emissions penalties now add an estimated €1.3 million in annual costs per ship. Global fuel instability and energy dependence – evidenced most recently by the closure of the Strait of Hormuz and dramatically reduced traffic through the Suez Canal – further compound the pressures of surging fuel and regulatory costs.

About Newlight

Newlight is a maritime energy company developing hydrogen injection systems for large commercial vessels. Led by co-founders Haran Cohen Hillel and Evyatar Cohen – former senior naval officers with engineering and management experience – Newlight’s mission is to accelerate the transition of the maritime industry towards cost-effective sustainable energy. Its hydrogen injection diesel engine retrofit has been proven to reduce fuel consumption and emissions by over 20% on long-range commercial voyages.

About lomarlabs

lomarlabs is a venture catalyst with a proven track record of advancing pioneering technologies across the maritime industry. Drawing on five decades of operational expertise from Lomar, its ship-owning and management parent company, it works alongside start-ups and innovators to develop, test, and scale solutions that support the decarbonisation, automation, and transformation of global shipping.

The lomarlabs Compass Programme provides the route from early validation to onboard deployment, supporting maritime deep-tech start-ups as they move from controlled environments into live commercial operations.

Photo – https://mma.prnewswire.com/media/3008921/Newlight_Vessel.jpg

Media Contact

Zack Rothbart, Concrete Media
[email protected]

SOURCE Newlight